...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New SEDAR page

"Thank you for your question. I want to assure you that the default flags appearing on Zenith’s SEDAR+ profile are not cause for concern. All necessary filings have been made (and are visible on our profile), and the fees are currently being processed. We expect the default flags to be removed shortly.

 

Best regards,

 

Chris"

Share
New Message
Please login to post a reply